Empagliflozin Changes Urine Supersaturation by Decreasing pH and Increasing Citrate.

Details

Request a copyRequest a copy
Serval ID
serval:BIB_B566D465A0A5
Type
Article: article from journal or magazin.
Publication sub-type
Letter (letter): Communication to the publisher.
Collection
Publications
Institution
UNIL/CHUV
Title
Empagliflozin Changes Urine Supersaturation by Decreasing pH and Increasing Citrate.
Journal
Journal of the American Society of Nephrology
Author(s)
Harmacek D., Pruijm M., Burnier M., Muller M.E., Ghajarzadeh-Wurzner A., Bonny O., Zanchi A.
ISSN
1533-3450 (Electronic)
ISSN-L
1046-6673
Publication state
Published
Issued date
06/2022
Peer-reviewed
Oui
Volume
33
Number
6
Pages
1073-1075
Language
english
Notes
Publication types: Letter ; Research Support, Non-U.S. Gov't
Publication Status: ppublish
Abstract
Clinical Trial registry name and registration number: Empagliflozin and Renal Oxygenation in Healthy Volunteers (EMPA-REIN), NCT03093103.
Keywords
Benzhydryl Compounds/therapeutic use, Citric Acid, Diabetes Mellitus, Type 2, Glucosides/therapeutic use, Healthy Volunteers, Humans, Hydrogen-Ion Concentration, Kidney Calculi, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, SGLT2, empagliflozin, healthy volunteers, kidney stones
OAI-PMH
oai:serval.unil.ch:BIB_B566D465A0A5
DOI
10.1681/ASN.2021111515
Pubmed
35387874
Web of science
000789860900001
Create date
25/04/2022 13:18
Last modification date
02/02/2023 7:52
Usage data